[CAS NO. 1706522-79-3]  PF-543 hydrochloride

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1706522-79-3]

Store
Catalog
SLK-S7177
Brand
Selleck
CAS
1706522-79-3

DESCRIPTION [1706522-79-3]

Overview

MDLMFCD28411614
Molecular Weight502.07
Molecular FormulaC27H32ClNO4S
SMILESOC[C@@H]1N(CC2=CC=C(COC3=CC(CS(=O)(C4=CC=CC=C4)=O)=CC(C)=C3)C=C2)CCC1.[H]Cl

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.9918 mL9.9588 mL19.9175 mL
5 mM0.3984 mL1.9918 mL3.9835 mL
10 mM0.1992 mL0.9959 mL1.9918 mL
50 mM0.0398 mL0.1992 mL0.3984 mL

Description

PF-543 hydrochloride, a novel sphingosine-competitive inhibitor of , inhibits SphK1 with and of 2.0 nM and 3.6 nM, exhibits >100-fold selectivity over the SphK2 isoform. PF-543 hydrochloride induces , necrosis, and .

Features

The most potent inhibitor of SphK1 described to date.

Targets

SphK1 [1]
(Cell-free assay)
SphK1 [1]
(Cell-free assay)
2.0 nM3.6 nM(Ki)

In vitro

PF543 is a cell-permeable hydroxyl methylpyrrolidine compound that inhibits SphK-1/SphK1-catalyzed sphingosine phosphorylation in a reversible and sphingosine-competitive manner, exhibiting no affinity toward S1P receptors and much reduced inhibitory activity against Sphk2 (6.8% inhibition at 10 μM) or 46 other lipid and portein kinases (IC50 >10 μM). In the SphK1-overexpression 1483 head and neck carcinoma cells, PF-543 decreases the level of endogenous S1P 10-fold with a proportional increase in the level of sphingosine. PF-543 binds SphK1 reversibly (k t1/2=8.5 min) and with high affinity and the binding constant (K) is 5 nM. PF543 had no effect on the proliferation and survival of 1483, A549, LN229, Jurkat, U937 and MCF-7 cells, despite a dramatic change in the cellular S1P/sphingosine ratio. PF-543 is effective as a potent inhibitor of S1P formation in whole blood, indicating that the SphK1 isoform of sphingosine kinase is the major source of S1P in human blood.